ArticleInternational journal of oncology2023
[Retracted] Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
Article in International journal of oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Following the publication of the above article, a concerned reader has drawn to the Editor's attention that there were a number of apparently overlapping data panels shown in Fig. 4C and D on p. 2360 such that the data would have drawn from a smaller number of original sources, where the data panels were intended to show the results from differently performed experiments. Moreover, certain of the data shown in Figs. 2D, 3B, C and E and 4F contained data that were strikingly similar to data that have appeared in other publications written by different authors at different research institutes. In view of the substantial number of overlapping data panels identified in Fig. 4C and D, and the fact that certain of the data in the above article have appeared in other published articles, the Editor of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.